Table 3 Binary Regression Analyses Regarding the Occurrence of HT.
Unadjust OR | 95% CI | P Value | Adjusted† OR | 95% CI | P Value | |
|---|---|---|---|---|---|---|
Age, per year | 1.038 | 0.999–1.079 | 0.056 | 1.004 | 0.961–1.050 | 0.857 |
Male sex | 1.776 | 0.754–4.184 | 0.189 | — | — | — |
NIHSS at baseline, per point | 1.062 | 1.007–1.120 | 0.027 | 1.047 | 0.985–1.113 | 0.140 |
ONT, per minutes | 0.996 | 0.990–1.002 | 0.201 | — | — | — |
DNT, per minutes | 1.003 | 0.993–1.014 | 0.551 | — | — | — |
Hypertension | 0.805 | 0.343–1.889 | 0.619 | — | — | — |
Diabetes mellitus | 1.035 | 0.432–2.481 | 0.939 | — | — | — |
Atrial fibrillation | 7.132 | 3.005–16.927 | <0.001 | 6.888 | 2.668–17.780 | <0.001* |
Coronary artery disease | 2.412 | 0.992–5.861 | 0.052 | 1.835 | 0.681–4.943 | 0.230 |
Current smoking | 0.683 | 0.419–1.114 | 0.127 | — | — | — |
Previous stroke | 0.590 | 0.197–1.768 | 0.346 | — | — | — |
Glucose, per mmol/L | 0.999 | 0.982–1.016 | 0.918 | — | — | — |
LDL-cholesterol, per mmol/L | 0.653 | 0.368–1.161 | 0.147 | — | — | — |
INR, per unit | 0.987 | 0.741–1.314 | 0.928 | — | — | — |
Antiplatelet medicine | 0.983 | 0.283–3.415 | 0.978 | — | — | — |
Anticoagulants medicine | 0 | 0 | 0.999 | — | — | — |
Level of albumin | 4.152 | 1.726–9.990 | 0.001 | 4.369 | 1.626–11.742 | 0.003* |
